Detalhe da pesquisa
1.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
N Engl J Med
; 386(12): 1143-1154, 2022 03 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35320644
2.
Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology.
BMC Cancer
; 22(1): 1201, 2022 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36419031
3.
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Lancet Oncol
; 17(6): 791-800, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27179402
4.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
N Engl J Med
; 366(2): 109-19, 2012 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-22149875
5.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncol
; 13(1): 25-32, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22153890
6.
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Lancet Oncol
; 12(3): 236-44, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21354370
7.
A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial.
Eur J Cancer
; 88: 21-30, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29179134
8.
[Cox-2 and CD105 expression in breast cancer and disease-free survival]. / Expressão da cox-2 e CD105 no câncer de mama e sobrevida livre de doença.
Rev Assoc Med Bras (1992)
; 52(4): 275-80, 2006.
Artigo
Português
| MEDLINE | ID: mdl-16967149
9.
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients.
Clinics (Sao Paulo)
; 71(10): 586-592, 2016 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27759847
10.
PAGET'S DISEASE IN A MALE PATIENT: CASE REPORT / Doença de Paget do mamilo em paciente masculino: relato de caso
Mastology (Impr.)
; 29(1): 51-54, jan.-mar.2019.
Artigo
Inglês
| LILACS | ID: biblio-988341
11.
Non-Hodgkin lymphoma in breast: case report / Linfoma naÌo Hodgkin da mama: relato de caso
Rev. bras. mastologia
; 27(1): 67-69, jan.-mar. 2017. ilus
Artigo
Inglês
|
LILACS-Express
| ID: biblio-832081
12.
The effect of neoadjuvant chemotherapy on hormone receptor status, HER2/neu and prolactin in breast cancer.
Tumori
; 97(6): 704-10, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22322835
13.
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
Clinics
; 71(10): 586-592, Oct. 2016. tab, graf
Artigo
Inglês
| LILACS | ID: lil-796864
14.
Uma nova plataforma terapêutica para o câncer de mama: a evoluçãodo tratamento sistêmico neoadjuvante / A new therapeutic platform for treating breast cancer: the evolution of systemic neoadjuvant treatment
Rev. bras. mastologia
; 25(1): 20-25, jan-mar 2015. graf
Artigo
Português
|
LILACS-Express
| ID: lil-782272
15.
Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?
Appl Immunohistochem Mol Morphol
; 18(1): 51-4, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19568168
16.
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
J Clin Oncol
; 26(4): 592-8, 2008 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18235117
17.
Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx.
Fertil Steril
; 85(1): 188-92, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16412752
18.
Recidiva locorregional: importância da margem cirúrgica livre e dos subtipos moleculares do câncer de mama / Locoregional recurrence: the importance of free surgical margins and molecular subtypes of breast cancer
Rev. bras. mastologia
; 21(4): 181-187, out.-dez. 2011.
Artigo
Português
| LILACS | ID: lil-722477
19.
Neoadjuvância sistêmica / Systemic neoadjuvance
Rev. bras. mastologia
; 20(3): 149-155, jul.-set. 2010. tab, ilus
Artigo
Português
| LILACS | ID: lil-608873
20.
A pesquisa clínica e o estado de arte / Clinical research and state of the art / Clinical research and state of the art / Investigación clínica y estado del arte
Rev. bras. mastologia
; 24(2): 35-35, abr.-jun. 2014.
Artigo
Português
|
LILACS-Express
| ID: biblio-39